California Cancer Reporting System Standards, Volume III

IF1245: TNM Clin T,N,M,In Situ (COC)

OWNER

CoC

EDIT SETS

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

FIELDS

Date of Diagnosis [NAACCR #390]

Primary Site [NAACCR #400]

Histologic Type ICD-O-3 [NAACCR #522]

Behavior Code ICD-O-3 [NAACCR# 523]

TNM Clin T [NAACCR #940]

TNM Clin N [NAACCR #950]

TNM Clin M [NAACCR #960]

TNM Clin Stage Group [NAACCR #970]

Age at Diagnosis [NAACCR #230]

CS Site-Specific Factor 10 [NAACCR #2864]

CS Site-Specific Factor25 [NAACCR #2879]

Grade [NAACCR #440]

Sex [NAACCR #220]

Type of Reporting Source [NAACCR# 500]

TABLE

AC7G2016.DBF

MESSAGE

  1. IF1245: For TNM Clin T [value], TNM Clin Stage Group [value] must be coded in situe stage group

  2. IF1245: For TNM Clin T [value], TNM Clin M [value] must be coded as negative for involvement

  3. IF1245: For TNM Clin T [value], TNM Clin N [value] must be coded as negative for involvement

specification

The purpose of this edit is to verify that TNM Clin N, TNM Clin M, and TNM Clin Stage Group are coded consistently for cases where TNM Clin T indicates an in situ tumor(TNM Clin T = pIS, pA, pISU, pISD, or pA).

 

This edit enforces the statement in the AJCC manual on page 12:  “Carcinoma in situ (CIS) is an exception to the stage grouping guidelines.  By definition, CIS has not involved any structure in the primary organ that would allow tumor cells to spread to regional nodes or distant sites.

 

This edit is skipped if any of the following conditions are true:

  1. Year of Date of Diagnosis is less than 2016, blank (unknown), or invalid

  2. Type of Reporting Source = 7

  3. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)

  4. TNM Clin T is not = pIS, pA, pISU, pISD, or pA

  5. TNM Edition Number not = 07, U7

 

If TNM Clin T = pIS, pA, pISU, or pISD:

TNM Clin N must = c0, c0A, c0B  (no clinically positive nodes)

TNM Clin M must = c0, c0I+ (metastasis clinically negative)

TNM Clin Stage Group must = 0, 0A, or 0IS (stage group clinical = in situ)

    

Only TNM Clin and TNM Clin M are edited for the following TNM groups.  In situ carcinomas are recognized by AJCC, but there is no stage grouping.

  

49. Carcinoma of Conjunctiva

50. Malignant Melanoma of Conjunctiva

 

This edit is skipped for the following TNM groups (AJCC does not recognize or does not stage in situ tumors for these sites, though in situ may be assigned by a pathologist):

 

7. Major Salivary Glands

8. Thyroid Gland (08A-08F)

9. Mucosal Melanoma Head and Neck

13B. Appendix, Carcinoid

16. GIST

17. NET Small Intestine and Ampulla of Vater, NET Colon and Rectum (17B, 17C)

18. Liver

36B. Corpus Sarcoma

36C. Corpus Adenosarcoma

37A. Ovary

39. Gestational Trophoblastic Tumors

41. Prostate

43. Kidney

47. Adrenal (47A, 47B)

51A. Melanoma of Choroid

51B. Melanoma of Iris

53. Carcinoma of the Lacrimal Gland

54. Sarcoma of the Orbit

57B. Primary Cutaneous Lymphoma

historical changes

In the SEER*Edits software, the title of this edit is: IF623.

11/2016

Per NAACCR v16B, new edit added.

03/2017

Per NAACCR v16D:

  • Added skip if TNM Edition Number not = 07,U7.

  • Modified logic, format of character string, e.g. "cxxb", 2,3.

  • In the SEER*Edits software the title of this edit is IF623.

  • Logic corrected to skip for site/histo group 009, Mucosal Melanoma of Head and Neck.

  • Logic corrected for invalid MATCH pattern If (not MATCH (#S"TNM Clin M", "c0, c0I{!+}")) (does not account for trailing blanks in field). Replaced with INLIST (no match mask).